Aurora Cannabis (ACB) Shares Outstanding (Weighted Average) (2018 - 2025)
Aurora Cannabis (ACB) reported Shares Outstanding (Weighted Average) of $5.0 billion for Q4 2025, little changed year-over-year from $5.0 billion in Q4 2024, and down 1.29% quarter-over-quarter from $5.1 billion in Q3 2025.
Aurora Cannabis (ACB) Shares Outstanding (Weighted Average) (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $5.0 billion in Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $5.0 billion, changed 0.45% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.0 billion (changed 0.45% YoY), and the FY2025 annual result was $4.9 billion, up 11936.44% from the prior year.
- Shares Outstanding (Weighted Average) retreated to $5.0 billion in Q4 2025 per ACB's latest filing, from $5.1 billion in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $5.2 billion in Q1 2022 and troughed at $23.4 million in Q2 2022.
- A 5-year average of $4.1 billion and a median of $5.1 billion in 2025 frame the typical range for Shares Outstanding (Weighted Average).
- On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 21754.2% in 2023 and fell as far as 99.51% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.1 billion in 2021, then fell by 1.26% to $5.0 billion in 2022, then climbed by 1.21% to $5.1 billion in 2023, then slipped by 1.99% to $5.0 billion in 2024, then climbed by 0.45% to $5.0 billion in 2025.
- Business Quant data shows ACB's Shares Outstanding (Weighted Average) at $5.0 billion in Q4 2025, $5.1 billion in Q3 2025, and $5.0 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.02 Bn |
| Sep 30, 2025 | 5.08 Bn |
| Jun 30, 2025 | 5.05 Bn |
| Mar 31, 2025 | 4.87 Bn |
| Dec 31, 2024 | 5.00 Bn |
| Sep 30, 2024 | 5.11 Bn |
| Jun 30, 2024 | 5.10 Bn |
| Mar 31, 2024 | 40.48 Mn |
| Dec 31, 2023 | 5.10 Bn |
| Sep 30, 2023 | 5.15 Bn |
| Jun 30, 2023 | 5.10 Bn |
| Mar 31, 2023 | 25.54 Mn |
| Dec 31, 2022 | 5.04 Bn |
| Sep 30, 2022 | 5.19 Bn |
| Jun 30, 2022 | 23.36 Mn |
| Mar 31, 2022 | 5.19 Bn |
| Dec 31, 2021 | 5.10 Bn |
| Sep 30, 2021 | 5.10 Bn |
| Jun 30, 2021 | 161.13 Mn |
| Mar 31, 2021 | 5.08 Bn |